Effectiveness of Group Therapy Based on Acceptance and Commitment on the Severity of Fatigue and Depression with the Moderating role of Alexithymia in Multiple Sclerosis Patients
International Clinical Neuroscience Journal,
Vol. 8 No. 1 (2021),
30 December 2020
Objective: Alexithymia is a symptom that most psychosomatic patients experience and can affect their performance, psychological state, and the severity of their physical symptoms. Therefore, the present study was conducted to determine the effectiveness of group therapy based on acceptance and commitment on the severity of fatigue and depression with the moderating role of alexithymia in MS patients in Tehran.
Methodology: In this research, a semi-experimental design was used with pre-test, post-test, and three months of follow-up. Using convenience sampling, 40 patients with MS were randomly assigned to two experimental and control groups. Before and after the intervention and three months later in the follow-up phase, all of the subjects responded to fatigue severity, depression, and alexithymia questionnaires. The intervention consisted of 10 sessions of 90-minutes group therapy based on acceptance and commitment, which was provided only to the experimental group.
Findings: Analysis of covariance indicated a significant difference between the mean scores of fatigue severity, depression, and alexithymia in the experimental and control groups in post-test and follow-up stages.
Conclusion: The findings of this study indicated the effectiveness of group therapy based on acceptance and commitment on reducing the severity of fatigue and depression with the moderating role of alexithymia in MS patients.
- acceptance and commitment based therapy
- severity of fatigue
- multiple sclerosis (MS).
How to Cite
Wingerchuk DM, Carter JL. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. InMayo Clinic Proceedings 2014 Feb 1 (Vol. 89, No. 2, pp. 225-240). Elsevier.
Azimian M, Shahvarughi-Farahani A, Rahgozar M, Etemadifar M, Nasr Z. Fatigue, depression, and physical impairment in multiple sclerosis. Iranian journal of neurology. 2014 Apr 3; 13(2):105.
Motaharinezhad F, Seyed S, Zeinali R. The impact of mental practice on sleep quality, fatigue, functional balance and gaiting in patient with multiple sclerosis: A case report. Koomesh. 2016 Apr 11:944-9.
Albuquerque C, Geraldo A, Martins R, Ribeiro O. Quality of life of people with multiple sclerosis: Clinical and psychosocial determinants. Procedia-Social and Behavioral Sciences. 2015 Jan 16; 171:359-65.
Čarnická Z, Kollár B, Šiarnik P, Krížová L, Klobučníková K, Turčáni P. Sleep disorders in patients with multiple sclerosis. Journal of Clinical Sleep Medicine. 2015 May 15; 11(05):553-7.
Motahari Nejad, Parvaneh, Shahriar, Ghahari, Setareh, Fatigue in Multiple Sclerosis Patients, Causes, Evaluation, and Treatment. Journal of Paramedical Sciences & Rehabilitation, 2016, Mar 20; 5(1):73-80.
Veauthier C, Hasselmann H, Gold SM, Paul F. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA Journal. 2016 Dec 1; 7(1):25.
Salehpoor G, Kafi SM, Rezaei S, Hosseininezhad M, Salehi I. The relation between fatigue severity with psychological symptoms and quality of life in multiple sclerosis. Zahedan Journal of Research in Medical Sciences. 2012 Nov 1; 14(9):80-6.
Pagnini F, Bosma CM, Phillips D, Langer E. Symptom changes in multiple sclerosis following psychological interventions: a systematic review. BMC Neurology. 2014 Dec; 14(1):222.
Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis-a systematic review. BMC neurology. 2014 Dec; 14(1):15.
Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP. Multiple sclerosis relapses and depression. Journal of psychosomatic research. 2012 Oct 1; 73(4):272-6.
Dehghan A, Memarian R. Abundance of stress, anxiety and depression in multiple sclerosis patients. Alborz university medical journal. 2013; 2(2):82-8.
Chalah MA, Ayache SS. Alexithymia in multiple sclerosis: a systematic review of literature. Neuropsychologia. 2017 Sep 1; 104:31-47.
Kano M, Fukudo S. The alexithymic brain: the neural pathways linking alexithymia to physical disorders. BioPsychoSocial medicine. 2013 Dec; 7(1):1.
Cerutti R, Calabrese M, Valastro C. Alexithymia and personality disorders in the adolescent non-suicidal self-injury: preliminary results. Procedia-Social and Behavioral Sciences. 2014 Feb 21; 114:372-6.
Eboni AC, Cardoso M, Dias FM, Gama PD, Gomes S, Goncalves MV, Machado SC, Nobrega Jr AW, Parolin MF, Paz SC, Ruocco HH. High levels of alexithymia in patients with multiple sclerosis. Dementia & Neuropsychologia. 2018 Jun; 12(2):212-5.
Rutten EA, Bachrach N, van Balkom AJ, Braeken J, Ouwens MA, Bekker MH. Anxiety, depression and autonomy–connectedness: The mediating role of alexithymia and assertiveness. Psychology and Psychotherapy: Theory, Research and Practice. 2016 Dec; 89(4):385-401.
Rezaei F, Karimi F, Afshari A, Hosseini-Ramadhani N. The correlation between alexithymia and anxiety, depression in asthma. Feyz 2017; 21(2): 178-87
Rostami Nezhad SR, Rad MM, Farrokhi N, Viesy F, Ghahari S. The relationship of alexithymia with depression, anxiety, stress, and fatigue among people under addiction treatment. Annals of Tropical Medicine and Public Health. 2017 Nov 1; 10(6):1698
Hulbert‐Williams NJ, Storey L, Wilson KG. Psychological interventions for patients with cancer: psychological flexibility and the potential utility of Acceptance and Commitment Therapy. European journal of cancer care. 2015 Jan; 24(1):15-27.
Burckhardt R, Manicavasagar V, Batterham PJ, Hadzi-Pavlovic D, Shand F. Acceptance and commitment therapy universal prevention program for adolescents: a feasibility study. Child and adolescent psychiatry and mental health. 2017 Dec; 11(1):27.
Baigan K, Khoshkonesh A, Habibi Askarabad M, Fallahzade H. [Effectiveness of dialectical behavioral group therapy in alexithymia, stress, and diabetes symptoms among type 2 diabetes patients]. J Diabetes Nurs. 2016; 4(2):8-18.
Nourian L, Aghaei A, Ghorbani M. The efficacy of acceptance and commitment therapy on weight self-efficacy lifestyle in obese women. J Mazandaran Univ Med Sci 2015; 25(123): 159-69. [In Persian].
Parsa, Maral, Sabahi, Mohammadi Far, The effectiveness of acceptance and commitment group therapy to improving the quality of life in patients with multiple sclerosis, Journal of Clinical Psychology, 2018, May 22;10(1):21-8.
Mousavi M, Hatami M, Nouryghasemabadi R. The Evaluation of effect of acceptance and commitment therapy on fatigue and anxiety in patients with breast cancer. Research in Medicine. 2017 Sep 1; 41(3):189-98.
Shahvarughi Farahani A, Azimian M, Fallahpour M, Karimlou M. Fatigue severity scale (fss): evaluation of reliability of the Persian version among persons with multiple sclerosis. Journal of Rehabilitation. 2010; 1051-46 :( 4) (Persian).
Wan Mahmud WMR, Awang A, Herman I, Mohamed. MN. Analysis of the Psychometric properties of the malay version of Beck Depression Inventory II (BDI-II) among postpartum women in Kedah, North West of Peninsular Malaysia. Malays J Med Sci. 2004;11(2):19–25.
Gallagher D, Nies G, Thompson LW. Reliability of the Beck Depression Inventory with older adults. J Consult Clin Psychol. 1982; 50(1):152–3.
Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian language version of the Beck Depression Inventory-Second edition: BDI-II-PERSIAN. Depress Anxiety. 2005; 21(4):185–92
Steer, R. A., Ball, R., Ranieri, W. F., & Beck, A. T. (1999). Dimensions of the Beck Depression Inventory‐II in clinically depressed outpatients. Journal of clinical psychology, 55(1), 117-128.
Leising, D., Grande, T., & Faber, R. (2009). The Toronto Alexithymia Scale (TAS-20): A measure of general psychological distress. Journal of Research in Personality, 43(4), 707-710.
Stivaleti Colombarolli, M., Carolina Zuanazzi, A., Koich Miguel, F., & Giromini, L. (2019). Psychometric properties of the Toronto Alexithymia Scale (TAS-20) in Brazil. Transcultural psychiatry, 56(5), 992-1010.
Veauthier C GG, Radbruch H, Gottschalk S, Wernecke, Paul F. Treatment of Sleep Disorders May Improve Fatigue in Multiple Sclerosis. Clinical neurology and neurosurgery 2013; 13.
Baseri LD, Bozorgi ZD. Effectiveness of Group Therapy Based on Acceptance and Commitment on Cognitive Emotion Regulation and Alexithymia of Patients with Type 2 Diabetes.Iranian Journal of Psychiatric Nursing (IJPN). 2017April 5(1):7-13.
Cote I, Trojan DA, Kaminska M, Cardoso M, Benedetti A, Weiss D, et al. Impact of Sleep Disorder Treatment on Fatigue in Multiple sclerosis. Mult Scler 2013; 19(4): 480-9.
Salehi N, Taher Neshat Dust H, Afshar H, Effectiveness of group therapy based on acceptance and commitment on psychological measures ( depression, anxiety, and stress) in female fibromyalgia patients, Journal of Behavioral Sciences, 2018, 16(1):78-83.
Parsa, M., Sabahi, P.,Mohammadifar, M.A. (2018). The effectiveness of acceptance and commitment group therapy to improving the quality of life in patients with multiple sclerosis. Journal Clinical Psychology, 10 (1), 21-28.
Tilaki, M., Taher, M., Mojarrad, A., Jafari Sani, B. Efficacy of Acceptance and Commitment Therapy on Psychological Flexibility and Alexithymia of Women with Chronic Pain. Journal of Psychological Studies, 2018; 14(3): 24-31.
Golshani, G., & Pirnia, B. (2019). Comparison of Mindfulness-Based Cognitive Therapy (MBCT) with Acceptance and Commitment Therapy (ACT) On the Severity of Fatigue, Improvement of Sleep Quality and Resilience in a Patient with Prostate Cancer: A Single-Case Experimental Study. International Journal of Cancer Management, 12(2).
- Abstract Viewed: 349 times
- PDF Downloaded: 361 times